Emmanuel Cherem, a 25-year-old gay man in Nigeria, tested positive for HIV two months after U.S. President Donald Trump's ...

The visit also served as an opportunity to explore how UNAIDS can support South Africa’s G20 Presidency and the country’s ...

More than half a million people previously diagnosed with HIV have started on HIV treatment since the end of February, the health minister says. But can a big jump in 10 weeks really be? We look at ...

About 21 000 HIV patients have disappeared from Mpumalanga’s treatment system, yet officials remain unclear or deny the ...

General, Winnie Byanyima, has called for a drastic and transparent reduction in the cost of lenacapavir, a twice-yearly ...

The FDA approved Gilead's HIV prevention drug lenacapavir, a twice-a-year injectable medication that clinical trials show ...

Gilead Sciences has received US FDA approval for Yeztugo, its bi-annual HIV prevention injection, which has shown 96 per cent ...

The Food and Drug Administration has approved the world’s only twice-a-year shot to prevent HIV. In two groundbreaking ...

In its latest budget request, the administration aims to slash 38 percent, or $2.9 billion, from the U.S. President’s ...

The United States has approved a twice-a-year jab that almost entirely protects against HIV in what’s being hailed as a ...

In two recent studies, this new shot reportedly nearly eliminated new infections in people at substantial risk of HIV.

Emmanuel Cherem, a 25-year-old gay man in Nigeria, tested positive for HIV two months after U.S. President Donald Trump's ...